Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 234,993,468 papers from all fields of science
Search
Sign In
Create Free Account
annamycin
Known as:
2'-iodo-3'-hydroxy-4'-epi-4-demethoxydoxorubicin
, 5,12-naphthacenedione, 7-((2,6-dideoxy-2-iodo-alpha-l-mannopyranosyl)oxy)-7,8,9,10-tetrahydro-6,9,11-trihydroxy-9-(hydroxyacetyl)-, (7S-cis)-
A lipophilic, anthracycline antineoplastic antibiotic. Annamycin intercalates into DNA and inhibits topoisomerase II, thereby inhibiting DNA…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
5 relations
Broader (2)
Antibiotics, Antineoplastic
Doxorubicin
NCIt Antineoplastic Agent Terminology
analogs & derivatives
Narrower (1)
annamycin liposomal
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Phase I/II Studies of Annamycin in Acute Myeloid Leukemia Report Positive Interim Results
H. Slater
2019
Corpus ID: 213793272
Additional positive interim safety and efficacy data were reported for annamycin in the treatment of patients with relapsed or…
Expand
2019
2019
PB1743 LIPOSOMAL ANNAMYCIN - A NEW GENERATION ANTHRACYCLINE THAT OVERCOMES MDR AND HAS NO CARDIAC TOXICITY FOR THE TREATMENT OF R/R AML
R. Shepard
HemaSphere
2019
Corpus ID: 196512027
2011
2011
doxorubicin in HL-60 leukemia cell lines related multidrug resistance: comparison with idarubicin and The novel anthracycline annamycin is not affected by P-glycoprotein-
U. Consoli
,
W. Priebe
,
+5 authors
M. Andreeff
2011
Corpus ID: 86259264
2001
2001
Aronex Pharmaceuticals reports on annamycin phase I trial.
Expert Review of Anticancer Therapy
2001
Corpus ID: 9598111
2000
2000
Treatment of Metastatic Breast Carcinoma Refractory to Doxorubicin with Liposomal-Annamycin
A. Sahin
2000
Corpus ID: 70781768
Abstract : We studied the toxicity and antitumor activity of Liposomal/Annamycin in patients with metastatic breast carcinoma…
Expand
1999
1999
Annamycin, a novel liposomally formulated anticancer agent
W. Priebe
,
D. Booser
,
R. Perez-soler
1999
Corpus ID: 83098309
1997
1997
Treatment of Metastatic Breast Carcinoma Refractory to Doxorubicin with Liposomal-Annamycin.
R. Perez-soler
1997
Corpus ID: 70927121
Abstract : Annamycin is a non-cross resistant doxorubicin analog that is formulated in a liposomal carrier. We have completed a…
Expand
1996
1996
Decreases in high density lipoprotein esterified cholesterol content alters the plasma distribution of annamycin and nystatin
S. Cassidy
,
K. Wasan
1996
Corpus ID: 103173329
1996
1996
Development of liposomal-annamycin
R. P. Soler
,
Y. Zou
,
W. Priebe
1996
Corpus ID: 196515570